[go: up one dir, main page]

AU2149797A - Therapeutic agents for asthma - Google Patents

Therapeutic agents for asthma

Info

Publication number
AU2149797A
AU2149797A AU21497/97A AU2149797A AU2149797A AU 2149797 A AU2149797 A AU 2149797A AU 21497/97 A AU21497/97 A AU 21497/97A AU 2149797 A AU2149797 A AU 2149797A AU 2149797 A AU2149797 A AU 2149797A
Authority
AU
Australia
Prior art keywords
agent
asthma
therapeutic agents
safely
immediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21497/97A
Other versions
AU728713B2 (en
Inventor
Akira Akashi
Yoshiyuki Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of AU2149797A publication Critical patent/AU2149797A/en
Application granted granted Critical
Publication of AU728713B2 publication Critical patent/AU728713B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The description relates to a therapeutic agent which comprises as the active agent a compound given by the formula (1) and/or (1') and/or a pharmaceutically acceptable salt thereof. The agent of the invention exhibits great effectiveness in cases of both immediate and later asthmatic reactions, especially the latter. Owing to its low toxicity, the agent of the invention can safely be prescribed for human beings.
AU21497/97A 1996-01-26 1997-01-27 Therapeutic agents for asthma Ceased AU728713B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1184896 1996-01-26
JP8-11848 1996-01-26
PCT/DE1997/000135 WO1997026968A2 (en) 1996-01-26 1997-01-27 Therapeutic anti-asthma agents containing selenium compounds

Publications (2)

Publication Number Publication Date
AU2149797A true AU2149797A (en) 1997-08-20
AU728713B2 AU728713B2 (en) 2001-01-18

Family

ID=11789151

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21497/97A Ceased AU728713B2 (en) 1996-01-26 1997-01-27 Therapeutic agents for asthma

Country Status (19)

Country Link
EP (1) EP0876144B1 (en)
CN (1) CN1116876C (en)
AT (1) ATE207746T1 (en)
AU (1) AU728713B2 (en)
BR (1) BR9707303A (en)
CA (1) CA2244085C (en)
CZ (1) CZ292670B6 (en)
DE (2) DE19780042D2 (en)
DK (1) DK0876144T3 (en)
EA (1) EA001066B1 (en)
ES (1) ES2165034T3 (en)
HU (1) HUP9901639A3 (en)
IL (1) IL124006A (en)
NO (1) NO983217L (en)
NZ (1) NZ330198A (en)
PL (1) PL187620B1 (en)
PT (1) PT876144E (en)
TR (1) TR199801398T2 (en)
WO (1) WO1997026968A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7671211B1 (en) 1999-03-31 2010-03-02 Arne Holmgren Substrates for thioredoxin reductase

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000016935A (en) 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd Cyclooxygenase inhibitor
RU2011141794A (en) 2009-03-17 2013-04-27 Дайити Санкио Компани, Лимитед AMIDE DERIVATIVE
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN105622478B (en) * 2014-10-27 2017-08-25 中国科学院大连化学物理研究所 The ketone derivatives of 3,3 2 alkylthio group, 2 phenylseleno, 2 propylene 1 and synthesis
CN109627198B (en) * 2019-02-01 2020-11-10 河南科技大学 2-acetonyl selenium-based benzamide compound and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DZ1460A1 (en) * 1989-11-22 2004-09-13 Sod Conseils Rech Applic New selenophen derivatives and their preparation process.
IT1250751B (en) * 1991-08-02 1995-04-21 Boehringer Mannheim Italia (3H, 7H) SELENAZOLO (3,4-A | PYRIDIN WITH ANTIASMATIC AND ANTIINFLAMMATORY ACTIVITIES OF THE AERIAL ROUTES
JP2553434B2 (en) * 1992-04-28 1996-11-13 第一製薬株式会社 Granular formulation
JPH07233056A (en) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd Lipoxygenase inhibitor
DE19506669A1 (en) * 1995-02-25 1996-08-29 Nattermann A & Cie Lipoxygenase inhibitor for treating asthma, tumours, shock etc.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7671211B1 (en) 1999-03-31 2010-03-02 Arne Holmgren Substrates for thioredoxin reductase

Also Published As

Publication number Publication date
CZ235698A3 (en) 1999-04-14
CZ292670B6 (en) 2003-11-12
PT876144E (en) 2002-04-29
ATE207746T1 (en) 2001-11-15
EP0876144B1 (en) 2001-10-31
WO1997026968A3 (en) 1997-09-25
HUP9901639A3 (en) 2000-10-30
BR9707303A (en) 2000-05-02
AU728713B2 (en) 2001-01-18
HK1019862A1 (en) 2000-03-03
NZ330198A (en) 2000-06-23
CN1116876C (en) 2003-08-06
CA2244085C (en) 2008-10-14
EA001066B1 (en) 2000-10-30
EP0876144A2 (en) 1998-11-11
ES2165034T3 (en) 2002-03-01
NO983217D0 (en) 1998-07-13
HUP9901639A1 (en) 1999-09-28
DE59705183D1 (en) 2001-12-06
EA199800658A1 (en) 1999-02-25
CN1219127A (en) 1999-06-09
IL124006A (en) 2004-07-25
TR199801398T2 (en) 1998-10-21
DK0876144T3 (en) 2002-02-25
NO983217L (en) 1998-09-25
PL187620B1 (en) 2004-08-31
CA2244085A1 (en) 1997-07-31
PL328198A1 (en) 1999-01-18
WO1997026968A2 (en) 1997-07-31
DE19780042D2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
WO1999063826A3 (en) Agents for combating plant pests
ZA95631B (en) Prolineamide derivatives
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
BG106586A (en) Pyrazolopyramidines as therapeutic agents
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
WO1998001440A3 (en) Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
CA2129542A1 (en) Pharmaceutical preparation based on rhamnolipid
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
CA2116829A1 (en) Use of a pregnane derivative
AU2149797A (en) Therapeutic agents for asthma
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
AU6117698A (en) Antiviral agents
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
WO1992017065A3 (en) Method of inhibiting fibrosis
GEP20043231B (en) Resorcinol Composition
CA2362211A1 (en) Benzamide derivatives and medicament containing the same
CA2132528A1 (en) Agent for use as an anti-irritant
CA2349452A1 (en) Therapeutic agents for drug dependence
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
WO2000002877A3 (en) New pharmaceutically active compounds
CA2370501A1 (en) Pharmaceutical composition for the therapy of lower urinary tract symptoms
WO1996033723A3 (en) Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness
AU1067795A (en) Use of lithium compounds in the treatment and prevention of alzheimer's disease
CA2288966A1 (en) Preventives and remedies for ulcerous colitis and/or crohn's disease

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)